Barry D. Quart, Director at Kiniksa Pharmaceuticals International, plc (KNSA), sold 13,099 shares at $50.10 ($656K) on 2026-04-28, disclosed to the SEC on 2026-04-29.
Scheduled sale ($656k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |
| KNSA | SELL | 2025-06-11 | $1.5M | — | Filing → |